Back to search
NUT Midline Carcinoma (NMC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NUT Midline Carcinoma (NMC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which NUT Midline Carcinoma (NMC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a study to determine the recommended dose of birabresib (MK-8628)(formerly known as OTX015) for further studies in participants with advanced nuclear pr…
Compassionate use access to molibresib/GSK525762 for eligible participant with NUT Midline Carcinoma; indication is a seriously debilitating or life-threatening…
This study is divided into two parts; Part 1 of the study is a dose escalation phase to select the recommended dose for Part 2 based on the safety, pharmacokine…
This is a Phase I, open-label, multi-center trial designed to evaluate the safety, tolerability and pharmacokinetics of CUDC-907 administered orally to subjects…